alexa Abstract | Human Immunodeficiency Virus: Discovery to Drug Resistance - A Review Update
ISSN: 2329-6577

Biological Systems: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


Since year 1983 when Human Immunodeficiency virus (HIV) was first discovered, there has been a spectacular progress in understanding the complex biology of the virus. Drug discovery accepted the challenge to stem spread of pathogenic virus that was characterized by unparalleled ability to alter, survive and kill humans. The genetic diversity of this virus, attributed to an extraordinary rate of mutation of the genome, is now the center of most of the scientific hurdles met towards its prevention and control. While the disease caused by HIV was staged by the medical community, a range of drugs were almost simultaneously discovered to address it. This was followed by the challenge of managing the menace of HIV drug resistance. The unique mechanism of host invasion and reduction in immune strength of the victim opened an additional area of concern by way of secondary infection which is now the prominent immediate cause of death of patients. In this review we take a panoramic view of this entire scenario and discuss the need for private sector to contribute to research and development in order to keep pace with the complexity of the virus and bring about a sustained solution to the alarming disease caused by it.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Arpan Acharya, Salil Vaniawala, Harsh Parekh, Rabindra Nath Misra, Minal Wani and Pratap N Mukhopadhyaya


Virus, Drug

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version